Cerebral 5-HT2A receptor binding, but not mGluR2, is increased in tryptophan hydroxylase 2 decrease-of-function mice

Neuroscience Letters

Volumn 555, Issue , 2013, Pages 118-122

  Jørgensen, Christinna V ^a   Jacobsen, Jacob P ^b   Caron, Marc G ^b   Klein, Anders B ^a   Knudsen, Gitte M ^a   Mikkelsen, Jens D ^a  

^a Rigshospitalet   (Denmark)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoradiography; Frontal cortex; Rat; Receptor; Serotonin; Tryptophan hydroxylase

Indexed keywords

2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; [2 (4 BROMO 2,5 DIMETHOXYPHENYL) N (2 METHOXYBENZYL)ETHANAMINE]; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; SEROTONIN 2A AGONIST; SEROTONIN 2A RECEPTOR; TRYPTOPHAN HYDROXYLASE 2; UNCLASSIFIED DRUG; VOLINANSERIN; AMINO ACID; METABOTROPIC RECEPTOR; RECEPTOR; SEROTONIN; TPH2 PROTEIN, MOUSE; TRYPTOPHAN HYDROXYLASE; XANTHENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; BRAIN LEVEL; BRAIN REGION; BRAIN STEM; CEREBELLUM; CORPUS STRIATUM; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; FRONTAL CORTEX; HIPPOCAMPUS; HYPOTHALAMUS; LIGAND BINDING; MOUSE; NONHUMAN; PARIETAL CORTEX; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR UPREGULATION; SUBSTANTIA NIGRA; ANIMAL; BRAIN; GENE TARGETING; GENETICS; METABOLISM; RADIOASSAY; RAT; TRANSGENIC MOUSE; UPREGULATION;

AUTORADIOGRAPHY; FRONTAL CORTEX; RAT; RECEPTOR; SEROTONIN; TRYPTOPHAN HYDROXYLASE;

AMINO ACIDS; ANIMALS; BRAIN; GENE KNOCK-IN TECHNIQUES; MICE; MICE, TRANSGENIC; RADIOLIGAND ASSAY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, METABOTROPIC GLUTAMATE; TRYPTOPHAN HYDROXYLASE; UP-REGULATION; XANTHENES;

EID: 84885463493     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.08.073     Document Type: Article

References (36)

1. Beaulieu J.M., Zhang X., Rodriguiz R.M., Sotnikova T.D., Cools M.J., Wetsel W.C., Gainetdinov R.R., Caron M.G. Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:1333-1338.
2. Bhagwagar Z., Hinz R., Taylor M., Fancy S., Cowen P., Grasby P. Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907. Am. J. Psychiatry 2006, 163:1580-1587.
3. Bortolozzi A., Diaz-Mataix L., Scorza M.C., Celada P., Artigas F. The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity. J. Neurochem. 2005, 95:1597-1607.
4. Braden M.R., Parrish J.C., Naylor J.C., Nichols D.E. Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists. Mol. Pharmacol. 2006, 70:1956-1964.
5. Cahir M., Ardis T., Reynolds G.P., Cooper S.J. Acute and chronic tryptophan depletion differentially regulate central 5-HT1A and 5-HT 2A receptor binding in the rat. Psychopharmacology (Berl) 2007, 190:497-506.
6. Celada P., Puig M., Amargos-Bosch M., Adell A., Artigas F. The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J. Psychiatry Neurosci. 2004, 29:252-265.
7. Cheetham S.C., Crompton M.R., Katona C.L., Horton R.W. Brain 5-HT2 receptor binding sites in depressed suicide victims. Brain Res. 1988, 443:272-280.
8. Compan V., Segu L., Buhot M.C., Daszuta A. Differential effects of serotonin (5-HT) lesions and synthesis blockade on neuropeptide-Y immunoreactivity and 5-HT1A 5-HT1B/1D and 5-HT2A/2C receptor binding sites in the rat cerebral cortex. Brain Res. 1998, 795:264-276.
9. Delille H.K., Becker J.M., Burkhardt S., Bleher B., Terstappen G.C., Schmidt M., Meyer A.H., Unger L., Marek G.J., Mezler M. Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades. Neuropharmacology 2012, 62:2184-2191.
10. Ettrup A., Hansen M., Santini M.A., Paine J., Gillings N., Palner M., Lehel S., Herth M.M., Madsen J., Kristensen J., Begtrup M., Knudsen G.M. Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers. Eur. J. Nucl. Med. Mol. Imaging 2011, 38:681-693.
11. Fell M.J., McKinzie D.L., Monn J.A., Svensson K.A. Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia. Neuropharmacology 2012, 62:1473-1483.
12. Fell M.J., Svensson K.A., Johnson B.G., Schoepp D.D. Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R 4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039). J. Pharmacol. Exp. Ther. 2008, 326:209-217.
13. Frokjaer V.G., Mortensen E.L., Nielsen F.A., Haugbol S., Pinborg L.H., Adams K.H., Svarer C., Hasselbalch S.G., Holm S., Paulson O.B., Knudsen G.M. Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder. Biol. Psychiatry 2008, 63:569-576.
14. Gonzalez-Maeso J., Ang R.L., Yuen T., Chan P., Weisstaub N.V., Lopez-Gimenez J.F., Zhou M., Okawa Y., Callado L.F., Milligan G., Gingrich J.A., Filizola M., Meana J.J., Sealfon S.C. Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature 2008, 452:93-97.
15. Grillon C., Cordova J., Levine L.R., Morgan C.A. Anxiolytic effects of a novel group II metabotropic glutamate receptor agonist (LY354740) in the fear-potentiated startle paradigm in humans. Psychopharmacology (Berl) 2003, 168:446-454.
16. Gunther L., Liebscher S., Jahkel M., Oehler J. Effects of chronic citalopram treatment on 5-HT1A and 5-HT2A receptors in group- and isolation-housed mice. Eur. J. Pharmacol. 2008, 593:49-61.
17. Heal D.J., Philpot J., Molyneux S.G., Metz A. Intracerebroventricular administration of 5,7-dihydroxytryptamine to mice increases both head-twitch response and the number of cortical 5-HT2 receptors. Neuropharmacology 1985, 24:1201-1205.
18. Jacobs B.L., Azmitia E.C. Structure and function of the brain serotonin system. Physiol. Rev. 1992, 72:165-229.
19. Jacobsen J.P., Siesser W.B., Sachs B.D., Peterson S., Cools M.J., Setola V., Folgering J.H., Flik G., Caron M.G. Deficient serotonin neurotransmission and depression-like serotonin biomarker alterations in tryptophan hydroxylase 2 (Tph2) loss-of-function mice. Mol. Psychiatry 2012, 17:694-704.
20. Johnson B.G., Wright R.A., Arnold M.B., Wheeler W.J., Ornstein P.L., Schoepp D.D. [3H]-LY341495 as a novel antagonist radioligand for group II metabotropic glutamate (mGlu) receptors: characterization of binding to membranes of mGlu receptor subtype expressing cells. Neuropharmacology 1999, 38:1519-1529.
21. Johnson M.P., Siegel B.W., Carr A.A. [3H]MDL 100 907: a novel selective 5-HT2A receptor ligand. Naunyn. Schmiedebergs Arch. Pharmacol. 1996, 354:205-209.
22. Kingston A.E., Ornstein P.L., Wright R.A., Johnson B.G., Mayne N.G., Burnett J.P., Belagaje R., Wu S., Schoepp D.D. LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors. Neuropharmacology 1998, 37:1-12.
23. Licht C.L., Marcussen A.B., Wegener G., Overstreet D.H., Aznar S., Knudsen G.M. The brain 5-HT4 receptor binding is down-regulated in the Flinders Sensitive Line depression model and in response to paroxetine administration. J. Neurochem. 2009, 109:1363-1374.
24. Maj J., Bijak M., Dziedzicka-Wasylewska M., Rogoz R., Rogoz Z., Skuza G., Tokarski T. The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain. Psychopharmacology (Berl) 1996, 127:73-82.
25. Meyer J.H., Kapur S., Eisfeld B., Brown G.M., Houle S., DaSilva J., Wilson A.A., Rafi-Tari S., Mayberg H.S., Kennedy S.H. The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study. Am. J. Psychiatry 2001, 158:78-85.
26. Meyer J.H., McMain S., Kennedy S.H., Korman L., Brown G.M., DaSilva J.N., Wilson A.A., Blak T., Eynan-Harvey R., Goulding V.S., Houle S., Links P. Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm. Am. J. Psychiatry 2003, 160:90-99.
27. Molinaro G., Traficante A., Riozzi B., Di Menna L., Curto M., Pallottino S., Nicoletti F., Bruno V., Battaglia G. Activation of mGlu2/3 metabotropic glutamate receptors negatively regulates the stimulation of inositol phospholipid hydrolysis mediated by 5-hydroxytryptamine2A serotonin receptors in the frontal cortex of living mice. Mol. Pharmacol. 2009, 76:379-387.
28. Moreno J.L., Holloway T., Albizu L., Sealfon S.C., Gonzalez-Maeso J. Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists. Neurosci. Lett. 2011, 493:76-79.
29. Patil S.T., Zhang L., Martenyi F., Lowe S.L., Jackson K.A., Andreev B.V., Avedisova A.S., Bardenstein L.M., Gurovich I.Y., Morozova M.A., Mosolov S.N., Neznanov N.G., Reznik A.M., Smulevich A.B., Tochilov V.A., Johnson B.G., Monn J.A., Schoepp D.D. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial. Nat. Med. 2007, 13:1102-1107.
30. Pehek E.A., Nocjar C., Roth B.L., Byrd T.A., Mabrouk O.S. Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex. Neuropsychopharmacology 2006, 31:265-277.
31. Pinborg L.H., Adams K.H., Yndgaard S., Hasselbalch S.G., Holm S., Kristiansen H., Paulson O.B., Knudsen G.M. [18F]altanserin binding to human 5HT2A receptors is unaltered after citalopram and pindolol challenge. J. Cereb. Blood Flow Metab. 2004, 24:1037-1045.
32. Rosel P., Arranz B., Urretavizcaya M., Oros M., San L., Navarro M.A. Altered 5-HT2A and 5-HT4 postsynaptic receptors and their intracellular signalling systems IP3 and cAMP in brains from depressed violent suicide victims. Neuropsychobiology 2004, 49:189-195.
33. Soria-Fregozo C., Perez-Vega M.I., Gonzalez-Burgos I., Feria-Velasco A., Beas-Zarate C. Prefrontal serotonergic denervation induces increase in the density of 5-HT2A receptors in adult rat prefrontal cortex. Neurochem. Res. 2008, 33:2350-2357.
34. Stanley M., Mann J.J. Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet 1983, 1:214-216.
35. Vaidya V.A., Marek G.J., Aghajanian G.K., Duman R.S. 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J. Neurosci. 1997, 17:2785-2795.
36. Zhang X., Gainetdinov R.R., Beaulieu J.M., Sotnikova T.D., Burch L.H., Williams R.B., Schwartz D.A., Krishnan K.R., Caron M.G. Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 2005, 45:11-16.